Artemis Therapeutics Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced operating income was USD 168,000 compared to USD 772,000 a year ago. Net loss was USD 121,000 compared to USD 513,000 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.08 a year ago.